Male Lower Urinary Tract Symptoms and Benign Prostatic Hyperplasia

Steven A. Kaplan, MD, E. Darracott Vaughan Jr. Professor of Urology, Director, Iris Cantor Men's Health Center, New York Presbyterian Hospital, New York, NY, USA Dr. Kaplan has had over 725 articles and 170 abstracts published and has made over 300 presentations in more than 35 countries. He is the author of two books and is on the Editorial Board of Urology, Journal of Urology, Wiley's BJUI and Urology Times. A member of more than 30 professional organizations, he is also a member of the WHO Committee on treating BPH, has been awarded 5 NIH grants and has received over 13 million dollars in research funding. He was awarded the John K. Lattimer Award for Lifetime Achievement in Urology by the National Kidney Foundation. Kevin T. McVary, MD, FACS, Professor and Chair, Division of Urology, Southern Illinois University School of Medicine, Springfield, IL, USA Dr. McVary is Chairman of both the AUA BPH Clinical Guidelines Committee and the Special Emphasis Urology Study Section for the NIDDK. He is Co-Chairman of the Clinical Section of the NIDDK Strategic Pathway for Prostate Basic and Clinical Science, and the AUA Honorary Speaker at the European Association of Urology (EAU). Dr. McVary has been principal investigator for more than 75 clinical trials and his research has generated more than 120 publications including journal articles, book chapters, and abstracts. His work has appeared in prominent journals such as the Journal of Urology, Journal of the American Medical Association (JAMA), New England Journal of Medicine, International Journal of Impotence Research, and Urology. He is an editorial consultant for the Journal of Andrology, Journal of Urology, Urology, Journal of Investigative Urology, Current Opinion in Urology, and Prostate Diseases.

1 Etiology and Pathogenesis Robert H. Getzenberg and Prakash Kulkarni 2 Lower Urinary Tract Symptoms and Benign Prostatic Hyperplasia: Epidemiology, Correlates and Risk Factors Raymond C. Rosen and Benjamin N. Breyer 3 Clinical Assessment and Diagnosis of Lower Urinary Tract Dysfunction (LUTD): United States Christopher P. Filson and John T. Wei 4 Clinical Assessment and Diagnosis of LUTS/BPH: Europe Stavros Gravas and Jean J.M.C.H. de la Rosette 5 Clinical Assessment and Diagnosis of LUTS/BPH: Primary Care Matt T. Rosenberg, John Riley and Marty M. Miner 6 Watchful Waiting Reginald Bruskewitz 7 Alpha-Adrenergic Antagonists for Lower Urinary Symptoms Secondary to Benign Prostatic Hyperplasia Nathaly Francois, Raunak D. Patel, Kevin T. McVary 8 5 -- Alpha Reductase Inhibitors (5-ARIs) Claudius, Fullhase and Roberto Soler 9 Anti-muscarinics Nadir I. Osman and Christopher R. Chapple 10 The use of pde-5 inhibitors in the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia Casey Lythgoe and Kevin T. McVary 11 Combination Medical Therapy for Male LUTS Claus G. Roehrborn 12 Complementary Therapy Aaron E Katz and Anne Darves-Bornoz 13 Open Simple Prostatectomy Annika Herlemann, Matthias Oelke and Christian Gratzke 14 Minimally Invasive Therapies Mauro Gacci, Matteo Salvi and Arcangelo Sebastianelli 15 Holmium Laser Therapy Peter Gilling 16 GreenLight Laser Therapy Alexis E. Te and Bilal Chughtai 17 Monopolar and Bipolar Transurethral Resection of the Prostate Aaron M. Bernie and Richard Lee